Innovation Pharmaceuticals Inc (IPIX)

[Empiricst1]

"So what happens if Brilacidin is shown to be effective on 15 of the 20 viruses that are being tested and then WHO decides to run Phase 2 studies on the 5 most promising?"

Probably nothing, as in vitro studies don't amount to much, just indications that a Ph1 or maybe even later, a Ph2 could pay off, if someone wants to take a chance funding a new Tamiflu. IPIX does not have the money and has the thinnest track record of getting outside licensing (just AS, right?). I am trying to be realistic. And unlikely the WHO would fund anything unless the Chinese gave the go ahead, see (https://www.theatlantic.com/politics/archive/2020/05/china-global-influence-who-united-states/611227/), and why would they?

That said, of course funding for wide-scoped anti-viral trials of Brilacidin would be great. Just not likely to happen, imo.